These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20671294)

  • 1. Effect of three different injection sites on the pharmacokinetics of the once-daily human GLP-1 analogue liraglutide.
    Kapitza C; Zdravkovic M; Zijlstra E; Segel S; Heise T; Flint A
    J Clin Pharmacol; 2011 Jun; 51(6):951-5. PubMed ID: 20671294
    [No Abstract]   [Full Text] [Related]  

  • 2. An open-label, parallel group study investigating the effects of age and gender on the pharmacokinetics of the once-daily glucagon-like peptide-1 analogue liraglutide.
    Damholt B; Golor G; Wierich W; Pedersen P; Ekblom M; Zdravkovic M
    J Clin Pharmacol; 2006 Jun; 46(6):635-41. PubMed ID: 16707410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of the pharmacokinetics, efficacy and safety of liraglutide.
    Bode B
    Diabetes Res Clin Pract; 2012 Jul; 97(1):27-42. PubMed ID: 22245694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability, pharmacokinetics and pharmacodynamics of the once-daily human GLP-1 analog liraglutide in Japanese healthy subjects: a randomized, double-blind, placebo-controlled dose-escalation study.
    Irie S; Matsumura Y; Zdravkovic M; Jacobsen LV; Kageyama S
    Int J Clin Pharmacol Ther; 2008 Jun; 46(6):273-9. PubMed ID: 18541123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and excretion of the once-daily human glucagon-like peptide-1 analog liraglutide in healthy male subjects and its in vitro degradation by dipeptidyl peptidase IV and neutral endopeptidase.
    Malm-Erjefält M; Bjørnsdottir I; Vanggaard J; Helleberg H; Larsen U; Oosterhuis B; van Lier JJ; Zdravkovic M; Olsen AK
    Drug Metab Dispos; 2010 Nov; 38(11):1944-53. PubMed ID: 20709939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics of liraglutide, a once-daily human glucagon-like peptide-1 analog, in healthy volunteers and subjects with type 2 diabetes, and comparison to twice-daily exenatide.
    Watson E; Jonker DM; Jacobsen LV; Ingwersen SH
    J Clin Pharmacol; 2010 Aug; 50(8):886-94. PubMed ID: 20133507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with liraglutide--a once-daily GLP-1 analog--does not reduce the bioavailability of ethinyl estradiol/levonorgestrel taken as an oral combination contraceptive drug.
    Jacobsen LV; Vouis J; Hindsberger C; Zdravkovic M
    J Clin Pharmacol; 2011 Dec; 51(12):1696-703. PubMed ID: 21228406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attempted suicide with liraglutide overdose did not induce hypoglycemia.
    Nakanishi R; Hirose T; Tamura Y; Fujitani Y; Watada H
    Diabetes Res Clin Pract; 2013 Jan; 99(1):e3-4. PubMed ID: 23149376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics, pharmacodynamics, and tolerability of liraglutide, a once-daily human GLP-1 analogue, after multiple subcutaneous administration in healthy Chinese male subjects.
    Jiang J; Zhang J; Jacobsen LV; Hu P
    J Clin Pharmacol; 2011 Dec; 51(12):1620-7. PubMed ID: 21273395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liraglutide - overview of the preclinical and clinical data and its role in the treatment of type 2 diabetes.
    Davies MJ; Kela R; Khunti K
    Diabetes Obes Metab; 2011 Mar; 13(3):207-20. PubMed ID: 21205109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liraglutide in clinical practice: dosing, safety and efficacy.
    Peterson GE; Pollom RD
    Int J Clin Pract Suppl; 2010 Oct; (167):35-43. PubMed ID: 20949699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liraglutide-induced acute pancreatitis.
    Jeyaraj S; Shetty AS; Kumar CR; Nanditha A; Krishnamoorthy S; Raghavan A; Raghavan K; Ramachandran A
    J Assoc Physicians India; 2014 Jan; 62(1):64-6. PubMed ID: 25327099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liraglutide: once-daily GLP-1 agonist for the treatment of type 2 diabetes.
    Ryan GJ; Hardy Y
    J Clin Pharm Ther; 2011 Jun; 36(3):260-74. PubMed ID: 21545609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of efficacy and safety data regarding the use of liraglutide, a once-daily human glucagon-like peptide 1 analogue, in the treatment of type 2 diabetes mellitus.
    Montanya E; Sesti G
    Clin Ther; 2009 Nov; 31(11):2472-88. PubMed ID: 20109994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liraglutide: from clinical trials to clinical practice.
    Gough SC
    Diabetes Obes Metab; 2012 Apr; 14 Suppl 2():33-40. PubMed ID: 22405267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Liraglutide: a human GLP-1 analogue for the treatment of diabetes mellitus type 2].
    Jahn E; Sausele T
    Med Monatsschr Pharm; 2009 Nov; 32(11):402-7. PubMed ID: 19947303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Beta-cell function in the foreground. GLP-1 based therapy of type 2 diabetes].
    Kern W
    MMW Fortschr Med; 2010 Jan; 151 Suppl 4():173-8. PubMed ID: 21595145
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of inhaled GLP-1 (MKC253): proof-of-concept studies in healthy normal volunteers and in patients with type 2 diabetes.
    Marino MT; Costello D; Baughman R; Boss A; Cassidy J; Damico C; van Marle S; van Vliet A; Richardson PC
    Clin Pharmacol Ther; 2010 Aug; 88(2):243-50. PubMed ID: 20592721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of the once-daily human glucagon-like peptide 1 analog liraglutide on the pharmacokinetics of acetaminophen.
    Kapitza C; Zdravkovic M; Hindsberger C; Flint A
    Adv Ther; 2011 Aug; 28(8):650-60. PubMed ID: 21792552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-generation GLP-1 therapy: an introduction to liraglutide.
    Repas T
    Postgrad Med; 2011 Sep; 123(5):239-47. PubMed ID: 21904107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.